Capricor

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.

About CAPR

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.

CEO

Linda Marbán

CEOLinda Marbán

Employees

160

Employees160

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1996

Founded1996

Employees

160

Employees160

CAPR Key Statistics

Market cap

349.21M

Market cap349.21M

Price-Earnings ratio

-5.38

Price-Earnings ratio-5.38

Dividend yield

—

Dividend yield—

Average volume

3.34M

Average volume3.34M

High today

$8.68

High today$8.68

Low today

$4.25

Low today$4.25

Open price

$7.00

Open price$7.00

Volume

19.66M

Volume19.66M

52 Week high

$23.40

52 Week high$23.40

52 Week low

$3.52

52 Week low$3.52

CAPR News

TipRanks 4h

Capricor Therapeutics Stock Plummets 40% on FDA Rejection

Capricor Therapeutics (CAPR) stock dove on Friday after the biotechnology company revealed a Complete Response Letter (CRL) from the U.S. Food and Drug Administ...

TipRanks 14h

Capricor Therapeutics price target lowered to $22 from $30 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Capricor Therapeutics (CAPR) to $22 from $30 and keeps an Overweight rating on the shares. The firm views t...

Benzinga 16h

Capricor's Lead Duchenne Therapy Hits FDA Regulatory Roadblock

Capricor Therapeutics Inc. CAPR stock is trading lower on Friday. The company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administrat...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CAPR. This list is generated using Robinhood data, and it’s not a recommendation.